Comparing two statins' effect on vitamin D after heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This study compares two common statins (atorvastatin and rosuvastatin) to see how they affect vitamin D levels in people who have recently had a heart attack or unstable angina. It may help doctors choose the best statin for your heart and vitamin D health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute coronary syndrome (a serious heart condition like a heart attack or unstable angina).
- Your vitamin D level is between 30 and 70 ng/mL (doctor can check with a blood test).
- You are not pregnant or breastfeeding.
- You are not allergic to statin drugs (like atorvastatin or rosuvastatin).
- You do not have high or low calcium levels, underactive thyroid, or abnormal liver/kidney function.
- You have not used vitamin D pills, cholesterol drugs, weight-loss drugs, or corticosteroids in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches to lowering 'bad' cholesterol (LDL-C) in people hospitalized with acute coronary syndrome (a heart attack or unstable angina). One approach uses two medications (a statin plus another pill), and the other uses three (adding an injectable medicine). The goal is to see if the triple therapy lowers cholesterol more effectively and helps prevent future heart problems.
This study compares two cholesterol treatment approaches after a heart attack: a lower dose combination versus a higher dose single medicine. It aims to see which option works well and is tolerable for people after a treated heart attack.
This trial tests how certain statin drugs (medicines that lower cholesterol) affect heart and blood vessel function in healthy people. If you are healthy, you may help researchers understand how these drugs work.
This study compares a new cholesterol medication combination to a standard high-intensity statin in patients aged 75 and older who have had a heart procedure to open blocked arteries. The goal is to see which treatment is better at managing cholesterol and reducing future heart risks.
This study compares two different ways of lowering cholesterol: a moderate statin (pitavastatin) plus another drug (ezetimibe) versus a stronger statin alone. The goal is to see which approach is safer regarding the risk of developing new diabetes.
This trial studies how well long-term cholesterol-lowering treatment works in people who recently had a heart attack (STEMI or NSTEMI). It may help your care team understand which patients benefit most and how treatment should be continued safely.
Hear when a new Acute Coronary Syndromes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.